Vortrag
Comparative safety and effectiveness of factor-xa inhibitors vs phenprocoumon in patients with non-valvular atrial fibrillation and diabetes
Speaker
Datum:
31.05.2019 ,
Zeit:
11:50
|
Thema: 03. Grundlagenforschung Typ-1-Diabetes/ Betazelle/ Typ-1-Diabetes/ Adipositas/ Fettgewebe
Details